Biomet is now Zimmer Biomet

X

Consent Message

This website may set one or more cookies on your computer. For information about cookies in general, and the specific ones that may be set by this website, please read our Cookies Policy. For information about managing cookies, including how to prevent them from being set on your computer, visit the All About Cookies website. Continued use of a Biomet website will be considered by us to be an expression of your consent to allow us to set one or more cookies on your computer.

Biomet
 
 

United Kingdom Change

Information for Medical Professionals

Avantage 3P

  • Cementless dual mobility cup with additional “3 point” fixation
     
  • Indicated for primary, revision and fracture in the treatment of patients at risk of instability

  • Paprosky grade 1, 2A and 2C




     

 

 

 

 

 

 

 

 ______________________________________________________________________

Avantage Acetabular System

Leading European national hip registries report that 12 to 16% of revision hip surgeries are due to dislocation1-3. This issue affects between 12,000 and 22,000 patients annually and therefore generates an estimated cost to healthcare providers of €58M to €78M each year4
 
Avantage is a Dual Mobility Acetabular System introduced by Biomet in 1998, to address patients with high risk of dislocation. Since 2005, the Avantage system has been the N°1 cementless and cemented dual mobility cup on the market5.

 

Key Features:

Dual Mobility Concept:

  • High range of motion
  • Low risk of dislocation
  • Low risk of PE wear
  • High long term stability

Proprietary Shell Design:

  • Superior Cap helps reduce risk of superior dislocation
  • Anatomic aperture helps reduce risk of impingement and increases ROM
  • Flattened pole helps increase peripheral load
  • Smooth superior-inferior transition helps reduce soft tissue irritation

E1 Antioxidant Infused Technology

  • Maximized strength
  • Maximized wear resistance
  • Prevention of oxidation
     

 Clinical Success:

  • 96.9% survival rate @ 9 years, National Joint Registry - England, Wales and NI6
  • 96.3% survival rate @ mean 7.2 years, Fresard et al, Multicentre Study7
  • 0.36% dislocation rate8
  • 7B ODEP rating

 

References

  1. Swedish Hip Arthroplasty Registry (2012)
  2. National Joint Registry for England Wales and Northern Island, 10th Annual Report, 2013
  3. Danish Hip Arthroplasty Register, Annual Report, 2011
  4. Biomet Market Analysis  - see appendix  for workings and references.
  5. Eucomed data reports. Period: 2005-2013
  6. NJR data extract, March 2014 – analysed by Biomet
  7. Fresard, PL. et al. Seven-year results of a press-fit, hydroxyapatite-coated double mobility acetabular component in patients aged 65 years or older. European Journal of Orthopeadic Surgery and Traumatology. 23:425–429, 2013.
  8. Mukka, S. et al. Dual Mobility Cups for Preventing Early Hip Arthroplasty Dislocation in Patients at Risk: Experience in a County Hospital. Orthopedic Reviews (Pavia). 5(2): e10, 2013.